Timothy Rolph
Net Worth
Last updated:
What is Timothy Rolph net worth?
The estimated net worth of Dr. Timothy Rolph is at least $21,348,210 as of 17 Dec 2024. He owns shares worth $8,471,008 as insider, has earned $9,772,202 from insider trading and has received compensation worth at least $3,105,000 in Akero Therapeutics, Inc..
What is the salary of Timothy Rolph?
Dr. Timothy Rolph salary is $621,000 per year as Co-Founder & Chief Scientific Officer in Akero Therapeutics, Inc..
How old is Timothy Rolph?
Dr. Timothy Rolph is 71 years old, born in 1954.
What stocks does Timothy Rolph currently own?
As insider, Dr. Timothy Rolph owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Akero Therapeutics, Inc. (AKRO) | Co-Founder & Chief Scientific Officer | 178,337 | $47.5 | $8,471,008 |
What does Akero Therapeutics, Inc. do?
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regulates metabolism of lipids, carbohydrates, and proteins throughout the body. It also conducts a Phase 2a clinical trial, the BALANCED study, to evaluate EFX in the treatment of biopsy-confirmed NASH patients. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.
Timothy Rolph insider trading
Akero Therapeutics, Inc.
Dr. Timothy Rolph has made 21 insider trades between 2020-2024, according to the Form 4 filled with the SEC. Most recently he sold 3,800 units of AKRO stock worth $118,172 on 17 Dec 2024.
The largest trade he's ever made was exercising 50,024 units of AKRO stock on 12 Mar 2020. As of 17 Dec 2024 he still owns at least 178,337 units of AKRO stock.
Akero Therapeutics key executives
Akero Therapeutics, Inc. executives and other stock owners filed with the SEC:
- Dr. Andrew Cheng (58) Pres, Chief Executive Officer & Director
- Dr. Jonathan M. Young (55) Co-Founder, Executive Vice President, Chief Operating Officer & Sec.
- Dr. Timothy Rolph (71) Co-Founder & Chief Scientific Officer
- Mr. William R. White J.D. (52) Executive Vice President, Chief Financial Officer, Treasurer & Head of Corporation Devel.